Immuno-PET of tissue factor in pancreatic cancer

Journal of Nuclear Medicine

Volumn 53, Issue 11, 2012, Pages 1748-1754

  Hong, Hao ^a   Zhang, Yin ^b   Nayak, Tapas R ^a   Engle, Jonathan W ^b   Wong, Hing C ^c   Liu, Bai ^c   Barnhart, Todd E ^b   Cai, Weibo ^a,b,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c ALTOR BIOSCIENCE CORPORATION   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

64Cu; Immuno PET; Monoclonal antibody; Pancreatic cancer; Positron emission tomography (PET); Tissue factor (TF)

Indexed keywords

1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID ALT 836 CU 64; THROMBOPLASTIN; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNO POSITRON EMISSION TOMOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; TISSUE DISTRIBUTION;

ANIMALS; CELL LINE, TUMOR; COPPER RADIOISOTOPES; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; IMMUNOGLOBULIN G; MICE; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOCHEMISTRY; RECOMBINANT PROTEINS; THROMBOPLASTIN;

EID: 84868325290     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.105460     Document Type: Article

References (40)

1. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097.
2. Nemerson Y. Tissue factor and hemostasis. Blood. 1988;71:1-8.
3. Hobbs JE, Zakarija A, Cundiff DL, et al. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res. 2007;120(suppl 2):S13-S21.
4. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med. 1996;2:209-215.
5. Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res. 2001;102:V215-V224.
6. Rickles FR, Levine MN. Epidemiology of thrombosis in cancer. Acta Haematol. 2001;106:6-12.
7. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212-236.
8. Khorana AA, Fine RL. Pancreatic cancer and thromboembolic disease. Lancet Oncol. 2004;5:655-663.
9. Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605-1617.
10. Haas SL, Jesnowski R, Steiner M, et al. Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation. World J Gastroenterol. 2006;12:4843-4849.
11. van den Berg YW, Osanto S, Reitsma PH, Versteeg HH. The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood. 2012; 119:924-932.
12. Guan M, Jin J, Su B, Liu WW, Lu Y. Tissue factor expression and angiogenesis in human glioma. Clin Biochem. 2002;35:321-325.
13. Hair GA, Padula S, Zeff R, et al. Tissue factor expression in human leukemic cells. Leuk Res. 1996;20:1-11.
14. Koomägi R, Volm M. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer. 1998;79:19-22.
15. Nitori N, Ino Y, Nakanishi Y, et al. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res. 2005;11:2531-2539.
16. Jiao JA, Kelly AB, Marzec UM, et al. Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site. Thromb Haemost. 2010;103:224-233.
17. Morris PE, Steingrub JS, Huang BY, et al. A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome. BMC Pulm Med. 2012;12:5.
18. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med. 2001;42(suppl): 1S-93S.
19. 18F-based radiotracers. Am J Nucl Med Mol Imaging. 2012;2:55-76.
20. Vach W, Høilund-Carlsen PF, Fischer BM, Gerke O, Weber W. How to study optimal timing of PET/CT for monitoring of cancer treatment. Am J Nucl Med Mol Imaging. 2011;1:54-62.
21. 11C-acetate. Am J Nucl Med Mol Imaging. 2012;2:33-47.
22. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med. 2002;8:1175-1181.
23. Temma T, Ogawa Y, Kuge Y, et al. Tissue factor detection for selectively discriminating unstable plaques in an atherosclerotic rabbit model. J Nucl Med. 2010;51:1979-1986.
24. Zhang Y, Hong H, Engle JW, Yang Y, Barnhart TE, Cai W. Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab. Am J Nucl Med Mol Imaging. 2012;2:1-13.
25. 89Zr-Df-TRC105. Eur J Nucl Med Mol Imaging. 2012; 39:138-148.
26. Cai W, Chen K, Mohamedali KA, et al. PET of vascular endothelial growth factor receptor expression. J Nucl Med. 2006;47:2048-2056.
27. 3. Cancer Res. 2006;66:9673-9681.
28. Milsom C, Magnus N, Meehan B, Al-Nedawi K, Garnier D, Rak J. Tissue factor and cancer stem cells: is there a linkage? Arterioscler Thromb Vasc Biol. 2009; 29:2005-2014.
29. Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol. 2009;27:4834-4838.
30. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002;2:897-909.
31. Laheru D, Jaffee EM. Immunotherapy for pancreatic cancer: science driving clinical progress. Nat Rev Cancer. 2005;5:459-467.
32. Wu AM. Antibodies and antimatter: the resurgence of immuno-PET. J Nucl Med. 2009;50:2-5.
33. Asa SL. Pancreatic endocrine tumors. Mod Pathol. 2011;24(suppl 2):S66-S77.
34. van Dam GM, Themelis G, Crane LM, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first inhuman results. Nat Med. 2011;17:1315-1319.
35. Yang Y, Zhang Y, Hong H, Liu G, Leigh BR, Cai W. In vivo near-infrared fluorescence imaging of CD105 expression. Eur J Nucl Med Mol Imaging. 2011; 38:2066-2076.
36. 111Indium labeled CXCR4 peptide antagonist. Am J Nucl Med Mol Imaging. 2012;2:99-109.
37. Hao G, Hajibeigi A, De León-Rodríguez LM,Öz OK, Sun X. Peptoid-based PET imaging of vascular endothelial growth factor receptor (VEGFR) expression. Am J Nucl Med Mol Imaging. 2011;1:65-75.
38. 64Cu-labeled antibody. Nucl Med Biol. 2011;38:29-38.
39. Hong H, Benink HA, Zhang Y, et al. HaloTag: a novel reporter gene for positron emission tomography. Am J Transl Res. 2011;3:392-403.
40. 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA. PLoS ONE. 2011;6:e28005.